This article is more than 5 years old. Information may no longer be current.

Guardion Health Sciences acquires VectorVision

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Guardion Health Sciences has acquired VectorVision, including trademarks, copyrights and other intellectual property, according to a press release.

VectorVision’s vision testing equipment, including its CSV-1000 device, is used by both clinicians and researchers, the release said.

Under the acquisition, Guardion will receive all of VectorVision’s assets in exchange for 3.05 million shares of its common stock. VectorVision’s founding shareholder David Evans, PhD, MBA, will join Guardion’s board of directors.

“We believe that the VectorVision acquisition marks just the beginning of the expansion of Guardion’s technology portfolio and demonstrates our commitment to building the company into the market leader in ocular health early detection and management,” Michael Favish, Guardion’s CEO and founder, said in the release.